HHS Extends Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies Contracts + Grants September 8, 2023 …
Regeneron Awarded $325M for Development of Next-Gen COVID-19 Monoclonal Antibody Therapy Industry News August 22, 2023 …
Project NextGen: HHS Awards $1.4B for COVID Countermeasure Development Contracts + Grants August 22, 2023 …
U.S. Invests in mAb Treatment for Ebola with New Award to Emergent BioSolutions Industry News July 31, 2023 …
NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies Medical Countermeasures January 12, 2023 …
U.S. Purchases 600,000 Courses of Eli Lilly Monoclonal Antibody That Works Against Omicron Medical Countermeasures February 10, 2022 …
Biodefense and Countering Disease with Neutralizing Antibodies Medical Countermeasures December 15, 2021 …
By Targeting Key Part of Spike Protein, This Antibody Protects Against Broad Range of COVID Variants Medical Countermeasures September 29, 2021 …
Coronavirus Immunotherapeutic Consortium Identifies Surfaces of Spike Most Resistant to Antibody Escape Pathogens September 26, 2021 …
WRAIR, Duke Scientists Find Evidence of Monoclonal Antibody Activity Against Malaria Medical Countermeasures March 5, 2021 …
Naval Medical Center San Diego Administers Hospital’s First mAb Treatment to COVID-19 Patient Infectious Diseases January 30, 2021 …
Regeneron Halts Trial for Antibody Cocktail in Sickest COVID-19 Patients Industry News October 30, 2020 …
Urgent Phase I/II Clinical Trial Funding to Repurpose Existing Therapeutics to Treat COVID-19 Contracts + Grants August 6, 2020 …
Antibodies from SARS Patient Blocks SARS and SARS-CoV-2 in Lab Medical Countermeasures May 23, 2020 …
